Literature DB >> 29912501

ORF15 exon of the RPGR gene in retinitis pigmentosa – technically difficult, diagnostically important.

Monika Ołdak, Ewelina Ruszkowska, Sylwia Siwiec, Agnieszka Pollak, Piotr Stawiński, Kamil Szulborski.   

Abstract

The aim of the study was to identify the genetic background of retinitis pigmentosa in a Polish family with previously excluded involvement of the majority of known genes for this disease, except for the ORF15 exon in the RPGR gene (Xp21.1). ORF15 is a highly repetitive, purine-rich DNA region with a number of different polymorphic variants and thus difficult to study. Genomic DNA was isolated from peripheral blood of the family members (n = 9). ORF15 exon was amplified in a long-range polymerase chain reaction and sequenced using the next generation method. Presence of the identified variant was confirmed by direct Sanger sequencing of the amplicon encompassing the mutation. The NM_001034853:c.2899delG (p.E967Kfs*122) mutation was detected in the ORF15 region. It completely segregated with the disease in the studied family. The identified alteration is pathogenic and has already been found to cause retinitis pigmentosa. It is estimated that more than a half of RPGR mutations are located in the ORF15 region. In families with a suspected X-linked inheritance of retinitis pigmentosa and in males with a negative family history of the disease, genetic tests should begin with an analysis of the ORF15.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 29912501

Source DB:  PubMed          Journal:  Klin Oczna        ISSN: 0023-2157


  1 in total

1.  Non-syndromic inherited retinal diseases in Poland: Genes, mutations, and phenotypes.

Authors:  Anna M Tracewska; Beata Kocyła-Karczmarewicz; Agnieszka Rafalska; Joanna Murawska; Joanna Jakubaszko-Jabłónska; Małgorzata Rydzanicz; Piotr Stawiński; Elżbieta Ciara; Beata S Lipska-Ziętkiewicz; Muhammad Imran Khan; Frans P M Cremers; Rafał Płoski; Krystyna H Chrzanowska
Journal:  Mol Vis       Date:  2021-07-16       Impact factor: 2.367

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.